Page last updated: 2024-09-05

mk 0852 and cangrelor

mk 0852 has been researched along with cangrelor in 1 studies

Compound Research Comparison

Studies (mk 0852)	Trials (mk 0852)	Recent Studies (post-2010) (mk 0852)	Studies (cangrelor)	Trials (cangrelor)	Recent Studies (post-2010) (cangrelor)
17	2	0	418	54	286

Protein Interaction Comparison

Protein	Taxonomy	mk 0852 (IC50)	cangrelor (IC50)
Ornithine decarboxylase	Rattus norvegicus (Norway rat)		0.0004
P2Y purinoceptor 12	Homo sapiens (human)		0.0043

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bath, PM; Fox, S; Heptinstall, S; Judge, H; Lösche, W; May, J; Zhao, L	1

Other Studies

1 other study(ies) available for mk 0852 and cangrelor

Article	Year
The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions. Current medical research and opinion, 2003, Volume: 19, Issue:3 Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD11b Antigen; Dipyridamole; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Leukocytes; Monocytes; Neutrophils; Oligopeptides; Peptides, Cyclic; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin	2003

Article

Year

The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions.

Current medical research and opinion, 2003, Volume: 19, Issue:3

Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD11b Antigen; Dipyridamole; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Leukocytes; Monocytes; Neutrophils; Oligopeptides; Peptides, Cyclic; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin

2003